FDA Inspection
WuXi Advanced TherapiesWuXi Advanced Therapies – FDA Inspection, Sep 1, 2023
Record Details
This FDA Inspection record concerns WuXi Advanced Therapies, with an inspection on September 1, 2023, issued by the Philadelphia District Office.
- Company
- WuXi Advanced Therapies
- Inspection Date
- September 1, 2023
View Company Profile
ID · c9716d0d-7be9-4919-9b44-36c3d85cf465
Inspection Facts
- Inspection number
- 1230154
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of WuXi Advanced Therapies
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2025 | Not classified | Philadelphia District Office | |
| February 7, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for WuXi Advanced Therapies
- FDA Inspection 1299454 - 2025-11-25
- FDA Inspection 1262215 - 2025-02-07
- FDA Inspection 1121335 - 2020-01-22
- FDA Inspection 921995 - 2015-04-17
- FDA Inspection 849366 - 2013-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.